News
MedInvest is hosting a MedTech, AI & Digital Health Conference December 10-11, 2025 in New York City. NIH National Cancer Institute’s Michael Salgaller will be speaking. He will be discussing NIH as a premier technology transfer partner, how the process at the NIH works, and answering questions

Seven scientists in the United States and Britain who have come up with a revolutionary gene therapy cure for a rare genetic form of childhood blindness won the 2018 António Champalimaud Vision Award, a 1 million euro prize from Portugal’s Champalimaud Foundation. Among them is Michael Redmond

Scientists from the National Institute of Aging (NIA) at National Institutes of Health (NIH) in collaboration with Tawain's National Health Research Institutes and Case Western Reserve University School of Medicine worked with Peptron Inc. a Korean-based public pharmaceutical company to develop a

Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health recently report that genetically modified broadly neutralizing antibodies (bNAbs) protected rhesus macaques from an HIV-like virus. Single infusions of each modified bNAb